Jan 30 (Reuters) - Amgen Inc:
* AMGEN RECEIVES CHMP POSITIVE OPINION TO ADD UPDATED OVERALL SURVIVAL DATA TO KYPROLISÂ® (CARFILZOMIB) LABEL Source text for Eikon: Further company coverage:
 